TrialLupus science & medicine2022

Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE.

Herbert Struemper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.